The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
Business Of Biotech
Transforming Biotech Landscapes
This chapter explores the journey of a couple transitioning from large biopharma to the biotech sector, focusing on innovations like allogeneic T-cell immunotherapy and groundbreaking therapies for transplant patients. It highlights the challenges faced during the pandemic, the importance of workplace culture, and how these experiences shaped their understanding of the cell therapy landscape. The discussion also emphasizes the critical role of leadership transitions, strategic planning, and the broader implications of advancements in gene editing and cell therapy technologies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
